Axtria has shared an update. The company announced that its Director of Clinical Excellence, Jo‑Zahn Baxter, will speak at the SCOPE 365 Summit about the transition from traditional electronic data capture (EDC) models to EMR2EDC, a process that integrates electronic medical records directly into clinical data systems. The session will focus on the organizational and change‑management challenges involved, rather than just the technology.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
For investors, this participation underscores Axtria’s positioning as a thought leader in life sciences data and clinical innovation. By engaging in industry forums on EMR2EDC and real‑world patient data, Axtria reinforces its relevance in a growing market segment where pharmaceutical and clinical research organizations are investing heavily in data integration and analytics. While the post does not disclose new contracts or financial metrics, active presence at specialized events like SCOPE 365 can support business development, strengthen relationships with clinical and life sciences clients, and potentially contribute to future revenue growth in Axtria’s analytics and technology services. It also highlights the company’s focus on higher‑value consulting and transformation work, which may support margin resilience over time if demand for EMR‑driven clinical data solutions continues to expand.

